Uncategorised - European Medical Journal

Children Drive RSV Spread Within U.S. Households

Respiratory syncytial virus (RSV) transmission in U.S. households was examined in a new study that showed young children are the primary drivers of infection, spreading the virus to adults and other household members.

Breakthrough Study Confirms Hepatitis E Vaccine Works in High-Risk Groups

A large-scale study finds that the hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic hepatitis B.

Epstein-Barr Virus as a Risk Factor for Multiple Sclerosis: New Insights

Groundbreaking research links EBV antibodies to MS via brain protein attacks. Genetic risks amplify danger, paving the way for targeted therapies.

Cancer Mortality Higher in Patients with Rheumatoid Arthritis

While patients with rheumatoid arthritis have a lower overall cancer incidence rate, they face higher post-cancer mortality.

Gut Microbiota Predicts Lung Cancer Treatment Outcomes

Gut microbiota composition may influence the efficacy and safety of chemo-immunotherapy in advanced non-small cell lung cancer.

RSV Resistance to Nirsevimab Remains Rare in Infants

A large-scale genomic surveillance study has found that resistance to nirsevimab in infants remains rare despite widespread use.

Garlic Intake May Increase Gastritis Risk in H. pylori-Infected Individuals

Garlic intake has long been touted for its health benefits, but new research suggests it may increase the risk of atrophic gastritis in individuals with H. pylori infections.

New Topical Treatment for Primary Axillary Hyperhidrosis

The study also highlighted the psychological burden of hyperhidrosis, linking the condition to increased anxiety, depression, and impaired quality of life.

Hidden Cognitive Decline in MS: A New Concern

Cognitive decline in relapsing-remitting multiple sclerosis (RRMS) can progress independently of both relapses and MRI-detected disease activity, challenging traditional methods of monitoring MS progression, according to the results of a new study.

Deep Learning Enhances NSCLC Treatment Precision

A deep learning model offering a powerful tool for predicting how patients with advanced non-small cell lung cancer (NSCLC) will respond to immune checkpoint inhibitors (ICIs), potentially improving treatment personalization, has been newly developed.